JAS239

Overview

JAS239 is a blood-brain barrier-permeable ChoK inhibitor. JAS239 inhibits phosphocholine synthesis and reduces the expression level of E2F1 protein. JAS239 exhibits near-infrared fluorescence properties. JAS239 exerts anti-tumor activity against glioblastoma. JAS239 can be used in studies related to glioblastoma.

Application

Products | Products > Disease Areas > CNS Neoplasm | Products > Disease Areas > Glioma | Products > Disease Areas > Glioblastoma | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Others | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Choline Kinase | Products > Signaling Pathways > Early 2 Factor (E2F) | Products > Signaling Pathways > Fluorescent Dye

Product Information

• Catalog No.: HY-123612
• CAS No.: 1630288-74-2
• Molecular Formula: C31H37ClN2O2
• Molecular Weight: 505.09
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source